ES523839A0 - Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos. - Google Patents

Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos.

Info

Publication number
ES523839A0
ES523839A0 ES523839A ES523839A ES523839A0 ES 523839 A0 ES523839 A0 ES 523839A0 ES 523839 A ES523839 A ES 523839A ES 523839 A ES523839 A ES 523839A ES 523839 A0 ES523839 A0 ES 523839A0
Authority
ES
Spain
Prior art keywords
sulphonics
imino
alpha
salts
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES523839A
Other languages
English (en)
Spanish (es)
Other versions
ES8403873A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Meram Les
Original Assignee
Laboratoires Meram Les
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Meram Les filed Critical Laboratoires Meram Les
Publication of ES8403873A1 publication Critical patent/ES8403873A1/es
Publication of ES523839A0 publication Critical patent/ES523839A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES523839A 1982-07-05 1983-07-04 Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos. Granted ES523839A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8211768A FR2529546A1 (fr) 1982-07-05 1982-07-05 Nouveaux sels d'amino-(et imino-)acides a, o-sulfoniques n-substitues, vecteurs cationiques de haute penetration cellulaire

Publications (2)

Publication Number Publication Date
ES8403873A1 ES8403873A1 (es) 1984-04-01
ES523839A0 true ES523839A0 (es) 1984-04-01

Family

ID=9275686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523839A Granted ES523839A0 (es) 1982-07-05 1983-07-04 Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos.

Country Status (8)

Country Link
US (1) US4563470A (enExample)
EP (1) EP0099799B1 (enExample)
JP (1) JPS6055067B2 (enExample)
AT (1) ATE18552T1 (enExample)
DE (1) DE3362536D1 (enExample)
ES (1) ES523839A0 (enExample)
FR (1) FR2529546A1 (enExample)
PT (1) PT76970B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100822525B1 (ko) * 1999-04-28 2008-04-16 뉴로겜 인터내셔널 리미티드 아밀로이드증 치료용 조성물 및 방법
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
AU2005310986A1 (en) * 2004-11-12 2006-06-08 Bellus Health (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
JP5145537B2 (ja) 2004-12-22 2013-02-20 ビーエイチアイ リミテッド パートナーシップ アミロイド関連疾患を治療するための方法および組成物
CN103787927B (zh) * 2006-10-12 2017-03-01 Bhi有限合资公司 递送3‑氨基‑1‑丙磺酸的方法、化合物、组合物和载体

Also Published As

Publication number Publication date
JPS6055067B2 (ja) 1985-12-03
ES8403873A1 (es) 1984-04-01
PT76970A (fr) 1983-07-01
EP0099799A1 (fr) 1984-02-01
FR2529546B1 (enExample) 1985-02-08
FR2529546A1 (fr) 1984-01-06
DE3362536D1 (en) 1986-04-17
PT76970B (fr) 1986-01-24
ATE18552T1 (de) 1986-03-15
JPS5921666A (ja) 1984-02-03
US4563470A (en) 1986-01-07
EP0099799B1 (fr) 1986-03-12

Similar Documents

Publication Publication Date Title
ES527027A0 (es) Procedimiento para preparar imidazolilalquiltien-2-il-tetrahidropiridazinas
ES8400082A1 (es) Procedimiento para la produccion de n-acilo-polipeptidos.
IE812565L (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl) alkonoic acids
ES526673A0 (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas
GR75859B (enExample)
ES523839A0 (es) Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos.
DE3070645D1 (en) Phosphoric acids and their derivatives
GR76735B (enExample)
DK0382067T3 (da) 3,7,11-Trimethyldodeca,2,4,6,10-tetraen-1-yl-phosphoniumsalte
JPS57109754A (en) N-benzoyl-omega-anilinoalkane carboxylic acid compound
ES2070602T3 (es) Procedimiento para la fabricacion de acrilatos alfa fluorados.
NO173106C (no) Korrosjonsbeskyttelsesmiddel
GR82125B (enExample)
ES506461A0 (es) Procedimiento para la obtencion de fosfonoformaldehido
SE7903971L (sv) Antitumordeoxiantracykliner
ES505203A0 (es) Proceso para producir en un antibiotico ka-6643-a.
DE3360169D1 (en) Chromophore peptides, process for their preparation, agents containing them and their use in the detection of dd-carboxy peptidases
DK245987D0 (da) Zink- og/eller blysalte af carboxylsyrer og anvendelse deraf som korrosionsbeskyttelsesmidler
ES2036613T3 (es) Fungicidas que contienen aminocompuestos.
SU1670971A1 (ru) Ингибитор коррозии алюминия в щелочных растворах
IE802690L (en) Substituted 2-phenylamino-imidazolines-(2)
ES525677A0 (es) Un procedimiento para la preparacion de n-(tio-1-oxopropil)-n-(4-fenilciclohexil)-glicinas.
SE8204641L (sv) Aminosyraderivat
GR69874B (enExample)
IE820678L (en) Methylphosphonic acid derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202